Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus

Cutan Ocul Toxicol. 2014 Sep;33(3):218-22. doi: 10.3109/15569527.2013.834497. Epub 2013 Oct 22.

Abstract

Purpose: To compare outcomes of accelerated and conventional corneal cross-linking (CXL) for progressive keratoconus (KC).

Materials and methods: Patients were divided into two groups as the accelerated CXL group and the conventional CXL group. The uncorrected distant visual acuity (UDVA), corrected distant visual acuity (CDVA), refraction and keratometric values were measured preoperatively and postoperatively. The data of the two groups were compared statistically.

Results: The mean UDVA and CDVA were better at the six month postoperative when compared with preoperative values in two groups. While change in UDVA and CDVA was statistically significant in the accelerated CXL group (p = 0.035 and p = 0.047, respectively), it did not reach statistical significance in the conventional CXL group (p = 0.184 and p = 0.113, respectively). The decrease in the mean corneal power (Km) and maximum keratometric value (Kmax) were statistically significant in both groups (p = 0.012 and 0.046, respectively in the accelerated CXL group, p = 0.012 and 0.041, respectively, in the conventional CXL group). There was no statistically significant difference in visual and refractive results between the two groups (p > 0.05).

Conclusions: Refractive and visual results of the accelerated CXL method and the conventional CXL method for the treatment of KC in short time period were similar. The accelerated CXL method faster and provide high throughput of the patients.

Keywords: Accelerated cross-linking; cross-linking; keratoconus.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Collagen / metabolism
  • Cornea / drug effects
  • Cornea / metabolism
  • Cross-Linking Reagents / therapeutic use*
  • Female
  • Humans
  • Keratoconus / drug therapy*
  • Keratoconus / metabolism
  • Keratoconus / physiopathology
  • Male
  • Photochemotherapy*
  • Radiation-Sensitizing Agents / therapeutic use*
  • Refraction, Ocular
  • Riboflavin / therapeutic use*
  • Ultraviolet Rays*
  • Visual Acuity
  • Young Adult

Substances

  • Cross-Linking Reagents
  • Radiation-Sensitizing Agents
  • Collagen
  • Riboflavin